Literature DB >> 29039218

The integration of genomics testing and functional proteomics in the era of personalized medicine.

Masaru Katoh1.   

Abstract

Keywords:  Breast cancer; FGFR1; FGFR2; FGFR3; FGFR4; WNT; gastric cancer; lung cancer; precision medicine; whole-genome sequencing

Mesh：

Year:  2017        PMID： 29039218     DOI： 10.1080/14789450.2017.1392245

Source DB:  PubMed          Journal:  Expert Rev Proteomics        ISSN： 1478-9450            Impact factor:   3.940


× No keyword cloud information.
  2 in total

1.  Combination immuno-oncology therapy with immune checkpoint blockers targeting PD-L1, PD-1 or CTLA4 and epigenetic drugs targeting MYC and immune evasion for precision medicine.

Authors:  Masaru Katoh
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

Review 2.  Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).

Authors:  Masaru Katoh
Journal:  Int J Mol Med       Date:  2018-05-17       Impact factor: 4.101
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.